Macquarie Group
NURO

Macquarie Group’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Macquarie Group’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-357
Closed -$58K – 2463
2017
Q3 		$58K Buy
+357
New +$58.8K ﹤0.01% 1991

Other funds holding NURO

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
OFS
Orrstown Financial Services Harrisburg, Pennsylvania $674M AUM 23.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Macquarie Group's NURO Position: Q4 2017 in Review

Macquarie Group sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2017, closing a stake of 357 shares — an estimated $58K sold.

Macquarie Group first reported a position in NURO in Q3 2017 and held it in 1 quarter. The position peaked at $58K in Q3 2017. 8 funds tracked by Wall St. Rank hold NURO as of Q4 2017.

  • Macquarie Group reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Macquarie Group sold 357 NeuroMetrix, Inc. Common Stock shares in Q4 2017, an estimated $58K.
  • Macquarie Group first reported a position in NeuroMetrix, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Macquarie Group's NeuroMetrix, Inc. Common Stock position peaked at $58K in Q3 2017.
  • 8 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2017.

Based on Macquarie Group's 13F filing for Q4 2017, filed 15 Feb 2018.